Traces the history of thrombotic thrombocytopenic purpura (TTP) from its first description in 1924 to the discovery in 1998 that most affected patients are severely deficient in von Willebrand factor-cleaving protease activity. Advances concerning pathophysiology, diagnosis and treatment; Controversies raised during the uears 1998-2004.